Cargando…

Novel Molecular Targets for Immune Surveillance of Hepatocellular Carcinoma

SIMPLE SUMMARY: Hepatocellular Carcinoma (HCC) is a common and aggressive cancer with limited treatment options. Approximately half of all patients with HCC receive systemic therapy during their disease course, particularly in the advanced stages of the disease. Immunotherapy has been paradigm-shift...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guerra, Pietro, Martini, Andrea, Pontisso, Patrizia, Angeli, Paolo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377787/ https://www.ncbi.nlm.nih.gov/pubmed/37509293 http://dx.doi.org/10.3390/cancers15143629

Ejemplares similares

Studies on the Role of Compartmentalized Profiles of Cytokines in the Risk of Hepatocellular Carcinoma
por: Fasolato, Silvano, et al.
Publicado: (2023)

PCSK9 Levels Are Raised in Chronic HCV Patients with Hepatocellular Carcinoma
por: Fasolato, Silvano, et al.
Publicado: (2020)

Novel molecular targets in hepatocellular carcinoma
por: Chow, Ariel Ka-Man, et al.
Publicado: (2020)

Serum Squamous Cell Carcinoma Antigen-Immunoglobulin M complex levels predict survival in patients with cirrhosis
por: Cagnin, Marco, et al.
Publicado: (2019)

Galad Score as a Prognostic Marker for Patients with Hepatocellular Carcinoma
por: Cagnin, Silvia, et al.
Publicado: (2023)

Molecular targeted and immune checkpoint therapy for advanced hepatocellular carcinoma
por: Liu, Ziyu, et al.
Publicado: (2019)

Potassium channels as novel molecular targets in hepatocellular carcinoma (Review)
por: Chen, Xingyue, et al.
Publicado: (2023)

Novel Molecular Targets for Hepatocellular Carcinoma
por: Cavalluzzo, Beatrice, et al.
Publicado: (2021)

Hepatocellular Carcinoma: Novel Molecular Targets in Carcinogenesis for Future Therapies
por: Bertino, Gaetano, et al.
Publicado: (2014)

Molecular Targets of Ferroptosis in Hepatocellular Carcinoma
por: Liao, Hao, et al.
Publicado: (2021)

Exploiting targeted nanomedicine for surveillance, diagnosis, and treatment of hepatocellular carcinoma
por: Liu, Tingting, et al.
Publicado: (2023)

Surveillance for hepatocellular carcinoma at the community level: Easier said than done
por: Del Poggio, Paolo, et al.
Publicado: (2021)

Liver pro-oncogenic potential of SERPINB3
por: Pontisso, Patrizia, et al.
Publicado: (2014)

Surveillance for Hepatocellular Carcinoma in Patients with NASH
por: Kolly, Philippe, et al.
Publicado: (2016)

MiR-122 Targets SerpinB3 and Is Involved in Sorafenib Resistance in Hepatocellular Carcinoma
por: Turato, Cristian, et al.
Publicado: (2019)

Hepatocellular Carcinoma: Molecular Mechanisms and Targeted Therapies
por: Alqahtani, Ali, et al.
Publicado: (2019)

Deubiquitinases: Novel Therapeutic Targets in Immune Surveillance?
por: Lopez-Castejon, Gloria, et al.
Publicado: (2016)

Hepatocellular Carcinoma: Surveillance, Diagnosis, Evaluation and Management
por: Elderkin, Jessica, et al.
Publicado: (2023)

Surveillance programmes for early detection of hepatocellular carcinoma
por: Simon, Krzysztof, et al.
Publicado: (2012)

Current and Emerging Tools for Hepatocellular Carcinoma Surveillance
por: Adeniji, Nia, et al.
Publicado: (2021)

Potential Molecular Targeted Therapy for Unresectable Hepatocellular Carcinoma
por: Kumar, Shashank, et al.
Publicado: (2023)

Hepatocellular Carcinoma: Past and Future of Molecular Target Therapy
por: Nguyen, Khanh, et al.
Publicado: (2015)

Molecular Targets, Pathways, and Therapeutic Implications for Hepatocellular Carcinoma
por: Gong, Jun, et al.
Publicado: (2020)

Molecular Signaling Pathways and Therapeutic Targets in Hepatocellular Carcinoma
por: Dimri, Manali, et al.
Publicado: (2020)

Molecular Mechanisms to Target Cellular Senescence in Hepatocellular Carcinoma
por: Mittermeier, Constanze, et al.
Publicado: (2020)

Anti-Hepatocellular Carcinoma Biomolecules: Molecular Targets Insights
por: Juaid, Nouf, et al.
Publicado: (2021)

The advanced development of molecular targeted therapy for hepatocellular carcinoma
por: Yan, Tao, et al.
Publicado: (2022)

Surveillance for Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease: Universal or Selective?
por: Plaz Torres, Maria Corina, et al.
Publicado: (2020)

Immune-based therapies for hepatocellular carcinoma
por: Pinato, David J., et al.
Publicado: (2020)

Yes-associated protein: A novel molecular target for the diagnosis, treatment and prognosis of hepatocellular carcinoma
por: Shan, Liang, et al.
Publicado: (2017)

Viral hepatitis and hepatocellular carcinoma: From molecular pathways to the role of clinical surveillance and antiviral treatment
por: Stella, Leonardo, et al.
Publicado: (2022)

Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Current Status and Novel Perspectives
por: Federico, Piera, et al.
Publicado: (2020)

Hepatic Resection for Hepatocellular Carcinoma in the Era of Molecular-targeted Agents and Immune Checkpoint Inhibitors in Japan
por: Taketomi, Akinobu
Publicado: (2021)

Hepatocellular carcinoma surveillance: Eastern and Western perspectives
por: Purcell, Yvonne, et al.
Publicado: (2019)

Targeted therapy for hepatocellular carcinoma: novel agents on the horizon
por: Cervello, Melchiorre, et al.
Publicado: (2012)

Surveillance of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease
por: Sumida, Yoshio, et al.
Publicado: (2020)

Molecular targets and oxidative stress biomarkers in hepatocellular carcinoma: an overview
por: Marra, Monica, et al.
Publicado: (2011)

Leptin signaling molecular actions and drug target in hepatocellular carcinoma
por: Jiang, Nan, et al.
Publicado: (2014)

Hepatocellular carcinoma: Therapeutic advances in signaling, epigenetic and immune targets
por: Neureiter, Daniel, et al.
Publicado: (2019)

Current Trends in Surgical Management of Hepatocellular Carcinoma
por: Angeli-Pahim, Isabella, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_aq1lfng2gjvsp14jh18g0afo6n